# Navi Seed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/navi-seed

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Latest round: Angel (Sep 16, 2022)
- Investors on record: 1

## About

Based in Suzhou, China, and founded in 2021, Navi Seed operates as a developer of minimally invasive interventional tumor surgery robot systems. The core team is composed of scientific researchers and clinical experts from Harbin Institute of Technology, Soochow University, South China University, and Peking University Third Hospital.

The company's core product, the radioactive particle implantation robot system has built a minimally invasive interventional technology platform for tumors. It can perform whole-body percutaneous puncture positioning and puncture path management and provide solutions for automatic radioactive particle implantation systems for solid tumors in the head and neck, chest, abdomen, and pelvis.

## Funding rounds

- Angel, Sep 16, 2022 — YuanMing Capital

## Investors

- YuanMing Capital (https://capitalatlas.ai/funds/yuanming-capital) — Angel